Biogen suffers setback after Alzheimer's drug fails to win support from FDA panel
November 06, 2020 at 16:40 PM EST
If fully approved, it would be the first drug to slow cognitive decline in people living with the disease and the first new treatment for Alzheimer's in nearly 20 years.
